Clinical trials
Suspended Phase 1 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adherex Technologies, Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Eisai Inc. | 1 |
| Eisai Limited | 1 |
| Envita Medical Center, Inc. | 1 |
| Exelixis | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| JS InnoPharm, LLC | 1 |
| Sabine Mueller, MD, PhD | 1 |
| Stanford University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 12 |
| Lung Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Prostatic Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colonic Neoplasms | 1 |
| Endometrial Neoplasms | 1 |
| Glioma | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.